<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>Insight数据库 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-04T20:21:26+08:00</updated>
  <subtitle>丁香园 Insight 数据库（db.dxy.cn），拥有申报、临床、上市、药企等 10 大核心数据。致力于分享医药行业政策解读、药企大事和药品申报情报等</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>73 个品种符合第四批集采！涉及 128 家企业</title>
    <updated>2020-12-04T18:43:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/Le_zaD34LZOACdrwxRwzSA</id>
    <link href="https://mp.weixin.qq.com/s/Le_zaD34LZOACdrwxRwzSA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>今日 4 款注射剂通过一致性评价，3 个为首家</title>
    <updated>2020-12-04T18:43:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/QobbyGiXObCmGaw-doIKCg</id>
    <link href="https://mp.weixin.qq.com/s/QobbyGiXObCmGaw-doIKCg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>遗传性血管性水肿新药来了！「拉那芦人单抗」在国内获批</title>
    <updated>2020-12-04T18:43:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/hkPTkwQj6hjDeB2SS7cXJA</id>
    <link href="https://mp.weixin.qq.com/s/hkPTkwQj6hjDeB2SS7cXJA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>正大天晴乙肝 1 类新药启动临床</title>
    <updated>2020-12-04T18:43:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/BLK-Y7NhtuK-cW4T1HErBQ</id>
    <link href="https://mp.weixin.qq.com/s/BLK-Y7NhtuK-cW4T1HErBQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>参会须知 | ICDC2020-第三届肿瘤免疫及伴随诊断合作峰会</title>
    <updated>2020-12-04T18:43:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/BFNraIr5PvcB6jjvc50hmg</id>
    <link href="https://mp.weixin.qq.com/s/BFNraIr5PvcB6jjvc50hmg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>首个国产 PARP 抑制剂！恒瑞 1 类新药「氟唑帕利胶囊」即将获批</title>
    <updated>2020-12-03T18:03:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/MwU0ApY37aXo79YnkZMRCA</id>
    <link href="https://mp.weixin.qq.com/s/MwU0ApY37aXo79YnkZMRCA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>海思科 1 类新药环泊酚即将获批</title>
    <updated>2020-12-03T18:03:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/KRSRGbl7KGB6JOZhwU5Iig</id>
    <link href="https://mp.weixin.qq.com/s/KRSRGbl7KGB6JOZhwU5Iig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>南京正大天晴「甲磺酸沙非胺片」首仿报上市</title>
    <updated>2020-12-03T18:03:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/-mK6Hd38YUdGQNd2VURKqw</id>
    <link href="https://mp.weixin.qq.com/s/-mK6Hd38YUdGQNd2VURKqw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞「瑞马唑仑」第 3 个适应症报上市，2020 医保谈判进行中</title>
    <updated>2020-12-02T17:12:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/XXFxDzirdzVnPHHvO_kLuw</id>
    <link href="https://mp.weixin.qq.com/s/XXFxDzirdzVnPHHvO_kLuw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>今日 5 款仿制药通过一致性评价，3 个注射剂，2 个首家过评</title>
    <updated>2020-12-02T17:12:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/YcVhr_y-zI6BrceqCqyi_w</id>
    <link href="https://mp.weixin.qq.com/s/YcVhr_y-zI6BrceqCqyi_w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>继续发力眼科领域，恒瑞干眼病新药 SHR8058 获批临床</title>
    <updated>2020-12-02T17:12:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/pQ1neu4vpWTUtOz4eV2fig</id>
    <link href="https://mp.weixin.qq.com/s/pQ1neu4vpWTUtOz4eV2fig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>潜在同类最佳，百济神州 Bcl-2 抑制剂获批临床</title>
    <updated>2020-12-02T17:12:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/wGkTQ9cKdRRuM-eXmeMnFA</id>
    <link href="https://mp.weixin.qq.com/s/wGkTQ9cKdRRuM-eXmeMnFA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第 32 批「通过一致性评价」名单来了</title>
    <updated>2020-12-01T18:00:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/HEpbIR6AIG2F0C7Ox-ET8Q</id>
    <link href="https://mp.weixin.qq.com/s/HEpbIR6AIG2F0C7Ox-ET8Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>贝达药业「埃克替尼」术后辅助治疗新适应症即将开展临床数据核查</title>
    <updated>2020-12-01T18:00:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/Cr4L5nAAX4gXvVG-IiW0Xw</id>
    <link href="https://mp.weixin.qq.com/s/Cr4L5nAAX4gXvVG-IiW0Xw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百济神州「泽布替尼胶囊」上市技术审评报告发布</title>
    <updated>2020-12-01T18:00:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/y0JBgw0WWfJxtK-DHJdZkg</id>
    <link href="https://mp.weixin.qq.com/s/y0JBgw0WWfJxtK-DHJdZkg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>南京正大天晴「注射用右雷佐生」报上市，奥赛康独家品种或受冲击？</title>
    <updated>2020-12-01T18:00:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/IHpwWRXyTQtX7UyQCNyrmg</id>
    <link href="https://mp.weixin.qq.com/s/IHpwWRXyTQtX7UyQCNyrmg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国生物制药三季报：营收 181.26 亿，研发投入 21 亿，抗肿瘤产品爆发！</title>
    <updated>2020-11-30T18:15:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/I5ZgcU2b7tNKUNwLLGQDIA</id>
    <link href="https://mp.weixin.qq.com/s/I5ZgcU2b7tNKUNwLLGQDIA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>生物药峰会！汇聚上海CPhI，5位行业大咖论道生物药研发新趋势！</title>
    <updated>2020-11-30T18:15:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/kh0NsYOExdbCLXZFnFcupw</id>
    <link href="https://mp.weixin.qq.com/s/kh0NsYOExdbCLXZFnFcupw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>诺华反义 RNA 疗法拟纳入突破性疗法！可降低心血管风险</title>
    <updated>2020-11-30T18:15:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/xDP42TKqyoL-yx0ZbXdhYg</id>
    <link href="https://mp.weixin.qq.com/s/xDP42TKqyoL-yx0ZbXdhYg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞医药「他达拉非片」获批上市</title>
    <updated>2020-11-30T18:15:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/tMi1XtuxywlitKYkjjb_wg</id>
    <link href="https://mp.weixin.qq.com/s/tMi1XtuxywlitKYkjjb_wg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>